direct to consumer DNA (genetic) testing; Ancestry DNA testing
Jump to navigation
Jump to search
Management
- patients with possible inherited disease should be referred for genetic testing only in the context of genetic counseling[3][5]
Notes
- unclear whether direct to consumer marketing of genomic testing results in better health outcomes[1][2]
- results of direct to consumer genetic testing should not influence healthcare decisions[2]
- confirm with clinical testing before using in medical decisions[2]
- issues of third-party identity & protection of privacy discussed[4]
More general terms
References
- ↑ 1.0 1.1 van der Wouden CH et al. Consumer perceptions of interactions with primary care providers after direct-to-consumer personal genomic testing. Ann Intern Med 2016 Mar 1; PMID: https://pubmed.ncbi.nlm.nih.gov/26928821
Burke W, Burke W, Trinidad SB. The deceptive appeal of direct-to-consumer genetics. Ann Intern Med 2016 Mar 1 PMID: https://pubmed.ncbi.nlm.nih.gov/26925528 - ↑ 2.0 2.1 2.2 2.3 Medical Knowledge Self Assessment Program (MKSAP) 17, 18, 19. American College of Physicians, Philadelphia 2015, 2018, 2021
Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025 - ↑ 3.0 3.1 Bellcross CA, Page PZ, Meaney-Delman D. Direct-to-consumer personal genome testing and cancer risk prediction. Cancer J. 2012 Jul-Aug;18(4):293-302. Review. PMID: https://pubmed.ncbi.nlm.nih.gov/22846729
- ↑ 4.0 4.1 May T Sociogenetic Risks - Ancestry DNA Testing, Third-Party Identity, and Protection of Privacy. N Engl J Med 2018; 379:410-412. Aug 2, 2018 PMID: https://pubmed.ncbi.nlm.nih.gov/29924688 Free full text https://www.nejm.org/doi/full/10.1056/NEJMp1805870
- ↑ 5.0 5.1 Gill J, Obley AJ, Prasad V. Direct-to-consumer genetic testing: the implications of the US FDA's first marketing authorization for BRCA mutation testing. JAMA. 2018;319:2377-2378. PMID: https://pubmed.ncbi.nlm.nih.gov/29800087